ConductScience.org, home

Paper17564707

Pharmacokinetics of decitabine administered as a 3-h infusion to patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).

Cashen AF and 4 others. Cancer Chemother Pharmacol, 2008. Cited by 80 papers, by iCite.

Cite this record

ConductScience Library. Pharmacokinetics of decitabine administered as a 3-h infusion to patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Papers, record 17564707. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17564707

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetics of decitabine administered as a 3-h infusion to patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
2008
PubMed
Publication types
Clinical Trial, Phase I, Journal Article
PubMed
Citations, by iCite
80
iCite
Relative citation ratio, by iCite
1.54
iCite
Revised in PubMed
2022-04-08
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cashen AFAmanda F
2Shah AKAjit K
3Todt LLaura
4Fisher NNicholas
5DiPersio JJohn

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antimetabolites, AntineoplasticMajor topic
AzacitidineMajor topic
Leukemia, Myeloid, AcuteMajor topic
Myelodysplastic SyndromesMajor topic
Adult
Aged
Aged, 80 and over
Area Under Curve
Bone Marrow
Chromatography, High Pressure Liquid
Decitabine
Drug Administration Schedule
Female
Half-Life
Humans
Infusions, Intravenous
Male
Mass Spectrometry
Middle Aged
Sepsis
Tissue Distribution

Source PubMed

Download CSV of topics

Cited by54

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.

PMIDTitleJournalYearIn PapersSource
41987339DNMT3A in cancer: from epigenetic writer to oncogenic driver.Clin Epigenetics2026https://conductscience.org/library/papers/41987339PubMed
41679964DAXX promotes SUMOylation of chromatin-trapped DNMT1.J Biochem2026https://conductscience.org/library/papers/41679964PubMed
41610325Synthetic lethality of decitabine plus ATR inhibition for TP53-mutated AML.Blood Adv2026https://conductscience.org/library/papers/41610325PubMed
41254518Decitabine-mediated DNA methylation dynamics at pericentromeric satellite 2 repeats.BMC Cancer2025https://conductscience.org/library/papers/41254518PubMed
39472491A multiomics approach reveals RNA dynamics promote cellular sensitivity to DNA hypomethylation.Sci Rep2024https://conductscience.org/library/papers/39472491PubMed
39169233Tumor editing suppresses innate and adaptive antitumor immunity and is reversed by inhibiting DNA methylation.Nat Immunol2024https://conductscience.org/library/papers/39169233PubMed
39006906Emerging applications of hypomethylating agents in the treatment of glioblastoma (Review).Mol Clin Oncol2024https://conductscience.org/library/papers/39006906PubMed
38760575Decitabine cytotoxicity is promoted by dCMP deaminase DCTD and mitigated by SUMO-dependent E3 ligase TOPORS.EMBO J2024https://conductscience.org/library/papers/38760575PubMed
38509812Clinical activity, pharmacokinetics, and pharmacodynamics of oral hypomethylating agents for myelodysplastic syndromes/neoplasms and acute myeloid leukemia: A multidisciplinary review.J Oncol Pharm Pract2024https://conductscience.org/library/papers/38509812PubMed
36536485DAB2IP attenuates chemoresistance of triple-negative breast cancer through sequestration of RAC1 to prevent β-catenin nuclear accumulation.Clin Transl Med2022https://conductscience.org/library/papers/36536485PubMed
35429619Recurrent transcriptional responses in AML and MDS patients treated with decitabine.Exp Hematol2022https://conductscience.org/library/papers/35429619PubMed
34257059Urinary retention after use of decitabine in acute myeloid leukemia: case report.Hematol Transfus Cell Ther2023https://conductscience.org/library/papers/34257059PubMed
34079760Decitabine Sensitizes the Radioresistant Lung Adenocarcinoma to Pemetrexed Through Upregulation of Folate Receptor Alpha.Front Oncol2021https://conductscience.org/library/papers/34079760PubMed
33958699Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies.Leukemia2021https://conductscience.org/library/papers/33958699PubMed
33437371Reactivation of oncogenes involved in G1/S transcription and apoptosis pathways by low dose decitabine promotes HT29 human colon cancer cell growth in vitro.Am J Transl Res2020https://conductscience.org/library/papers/33437371PubMed
31375673Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML.Nat Commun2019https://conductscience.org/library/papers/31375673PubMed
30962963Phase I clinical trial of decitabine (5-aza-2'-deoxycytidine) administered by hepatic arterial infusion in patients with unresectable liver-predominant metastases.ESMO Open2019https://conductscience.org/library/papers/30962963PubMed
30579366Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies.Diagn Pathol2018https://conductscience.org/library/papers/30579366PubMed
30214687Vitamin C promotes decitabine or azacytidine induced DNA hydroxymethylation and subsequent reactivation of the epigenetically silenced tumour suppressor CDKN1A in colon cancer cells.Oncotarget2018https://conductscience.org/library/papers/30214687PubMed
29708513DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine.J Clin Invest2018https://conductscience.org/library/papers/29708513PubMed

See all 54 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17564707

GET https://conductscience.org/api/papers/v1/17564707/cited_by?page=2